# PhaseBio Pharmaceuticals Inc: Form D filings

PhaseBio Pharmaceuticals Inc, a pharmaceuticals company in Malvern, PA, filed 8 Form D notices with the SEC between 2009 and 2018. The latest, on September 10, 2018, reports $26 million sold of a $32.1 million offering to 20 investors.

Find out what PhaseBio Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PhaseBio%20Pharmaceuticals%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PhaseBio%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fphasebio-pharmaceuticals-inc-1169245)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PhaseBio%20Pharmaceuticals%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PhaseBio%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fphasebio-pharmaceuticals-inc-1169245)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: One Great Valley Parkway, Suite30, Malvern, PA, 19355
- Phone: (610) 981-6500
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1169245

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 10, 2018 | New notice | $32,125,000 | $25,998,130 | $6,126,870 | 20 | Aug 27, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924518000001/0001169245-18-000001-index.htm) |
| Jan 31, 2017 | New notice | $7,875,000 | $6,615,000 | $1,260,000 | 9 | Jan 17, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924517000002/0001169245-17-000002-index.htm) |
| Jul 21, 2015 | Amendment | $42,000,000 | $21,000,000 | $21,000,000 | 9 | Feb 26, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924515000002/0001169245-15-000002-index.htm) |
| Mar 12, 2015 | New notice | $40,000,000 | $20,000,000 | $20,000,000 | 8 | Feb 26, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924515000001/0001169245-15-000001-index.htm) |
| Jun 18, 2012 | Amendment | $48,524,067 | $48,524,067 | $0 | 17 | Dec 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924512000001/0001169245-12-000001-index.htm) |
| Dec 6, 2010 | Amendment | $25,300,001 | $25,300,001 | $0 | 12 | Dec 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924510000002/0001169245-10-000002-index.htm) |
| Jan 5, 2010 | New notice | $25,300,001 | $10,120,000 | $15,180,001 | 12 | Dec 22, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924510000001/0001169245-10-000001-index.htm) |
| Nov 12, 2009 | New notice | $1,000,000 | $999,999 | $1 | 6 | Nov 3, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1169245/000116924509000004/0001169245-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jonathan Mow | Executive Officer, Director |  |
| Linda Tufts | Director |  |
| Justin Klein | Director |  |
| Clay Thorp | Director |  |
| Bibhash Mukhopadhyay | Director |  |
| John Sharp | Executive Officer |  |
| Nancy Hutson | Director |  |
| Caroline Loewy | Director |  |
| Tyrell Rivers | Director |  |

## Other pharmaceuticals companies in Pennsylvania that filed recently

- [Telemachus Therapeutics, Inc.](https://specstream.ai/data/form-d/company/telemachus-therapeutics-inc-2152986) $375,000 · Oct 28, 2026
- [EpiVario Inc.](https://specstream.ai/data/form-d/company/epivario-inc-1753351) $185,000 · Oct 13, 2026
- [Maxona Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/maxona-pharmaceuticals-inc-1857448) $5.8 million · Aug 14, 2026

[Every Form D from the week of Sep 10, 2018](https://specstream.ai/data/form-d/week/2018-09-10) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what PhaseBio Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).